---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Diabetes Tracker - myGlucose"
developer_entity: "Pratik Kadam"
bundle_id: "com.bloodsugarmonitorapp.diabetestrackerlog"
app_store_id: "6759655061"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2026-03-02"
report_date: "2026-08-26"
last_verified: "2026-08-26T00:00:00.000Z"
report_version: "1.0"
total_reviews: 4
overall_rating: 5
confidence: "low"
confidence_score: 0.05
data_age_days: 35
momentum_velocity: "zombie"
intelligence_version: 3
tags: ["medical", "free", "mobile app", "app review", "app analysis", "individuals", "managing", "diabetes,"]
canonical_url: "https://marlvel.ai/apps/diabetes-tracker-myglucose"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Diabetes Tracker - myGlucose Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Rating 5

> **TL;DR:** Diabetes Tracker - myGlucose is a medical app by Pratik Kadam, rated 5/5 by 4 users, available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Diabetes Tracker - myGlucose is a medical app by Pratik Kadam.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 5/5 (4 reviews) |
| **Category** | Medical |
| **Developer** | Pratik Kadam |
| **Pricing** | Free |
| **Platforms** | iOS |
| **Confidence** | Low (0.05/1.0) |
| **Data Age** | 35d |

## Metadata & Market Performance
- **Publisher:** Pratik Kadam
- **Category:** Medical
- **Target Audience:** Individuals managing type 1 diabetes, type 2 diabetes, or prediabetes who require a manual logging tool for glucose monitoring.
- **Platforms:** iOS
- **Version Reviewed:** 1.0
- **Report Date:** 2026-08-26
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.05/1.0)
- **App Store ID (iOS):** 6759655061
- **Bundle ID:** com.bloodsugarmonitorapp.diabetestrackerlog
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-08-26

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Diabetes Tracker - myGlucose is a manual blood sugar logging tool for individuals managing diabetes or prediabetes, available on iOS.
**Why users hire it:** The app removes the cognitive friction of complex interfaces for users who prefer a simple, manual record of their daily glucose readings over automated, high-maintenance alternatives.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Glucose Logging:** Manual entry of blood glucose levels including fasting and post-meal readings.
- **[Standard] Trend Visualization:** Charts and graphs displaying blood sugar changes over weeks and months.
- **[Standard] History Log:** Centralized repository for all historical glucose readings.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Diabetes Tracker - myGlucose maintains a low-profile presence with only 4 ratings on the iOS platform. The lack of updates since March 2026 signals a maintenance-only posture that prevents it from competing with active, feature-rich medical trackers.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free to download and use
- **Analysis:** The app is currently free with no visible subscription gates or monetization mechanics.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Minimalist interface reduces logging friction for manual-entry users

**Growth Levers:**
- Apple Health integration would provide a necessary data-sync differentiator


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The competitive outlook shifted from stable to declining, reflecting the increased risk of obsolescence as the app remains in a zombie state while the broader market adopts automated data synchronization.

**Overall trend**: Declining
**Compared at**: 2026-08-26

### High-impact changes
- **[Declined] Outlook Trend Downgrade** (positioning)

### Medium-impact changes
- **[Added] New SWOT Risk Factors** (swot)

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Zero updates since March 2026 launch.
- Maintenance-only posture limits growth.

> **Cadence:** 1 total versions · 1 majors in last 6 months · 176 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Diabetes Tracker - myGlucose is a medical app that is completely free.
It holds a 5/5 rating from 4 reviews.

<!-- speakable-start -->
> **Bottom Line:** Diabetes Tracker - myGlucose remains a static manual-entry tool in a market that has moved toward automated synchronization. Integrating Apple Health would unlock the utility required to remain relevant against modern, automated glucose-tracking alternatives.
<!-- speakable-end -->

**Best for:** Individuals managing type 1 diabetes, type 2 diabetes, or prediabetes who require a manual logging tool for glucose monitoring.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Audit Apple Health integration feasibility because manual-only entry is a category-wide churn risk → improve retention
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Declining

The glucose-tracking category is rapidly consolidating around automated data synchronization and CGM integration. Diabetes Tracker - myGlucose is currently exposed due to its manual-only design and lack of development activity, which will likely lead to further loss of relevance as users migrate to more integrated solutions.

- 🔴 The 6-month development silence since the March 2026 launch indicates a zombie-state product, which erodes user trust in long-term data reliability.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 5/5 |
| Total Reviews | 4 |
| Confidence | Low |
| Pricing Model | Free |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Diabetes Tracker - myGlucose** (this app) | 5/5 | N/A | Pratik Kadam |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Pratik Kadam

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/diabetes-tracker-myglucose/id6759655061?uo=4)
- **Sources:** App store metadata.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating
- [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 35 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/diabetes-tracker-myglucose)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.